Pharmacoeconomic Evaluation of Abiraterone Acetate Versus Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer in Kazakhstan
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.513
https://www.valueinhealthjournal.com/article/S1098-3015(13)02418-2/fulltext
Title :
Pharmacoeconomic Evaluation of Abiraterone Acetate Versus Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer in Kazakhstan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02418-2&doi=10.1016/j.jval.2013.08.513
First page :
A412
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
494